Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs (Q28217412)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs	scientific article

Statements

scholarly article

0 references

Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs (English)

0 references

Jens Kågström

1

object named as

Jens Kågström

0 references

author name string

Jens Kågström

1

0 references

Eva-Lena Sjögren

2

0 references

Ann-Christin Ericson

3

0 references

language of work or name

0 references

publication date

2007

1 reference

Journal of Pharmacological and Toxicological Methods

0 references

56

0 references

2

0 references

186-93

0 references

QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Computerized evaluation of drug-induced changes in guinea-pig epicardial monophasic action potentials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: a multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Effect of carvedilol on atrioventricular conduction in the ischemic heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Case of polymorphic ventricular tachycardia in diphenhydramine poisoning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: evaluation of the potential of compounds to cause QT interval prolongation by action potential assays using guinea-pig papillary muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Diphenhydramine overdose and Brugada sign

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

A new guinea-pig model for acute inhalation studies on combined effects of cold air and pollutants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Sino-atrial nodal cells of mammalian hearts: ionic currents and gene expression of pacemaker ionic channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Prolonged QT interval with markedly abnormal ventricular repolarization in diphenhydramine overdose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Monophasic action potential in anaesthetized guinea pigs as a biomarker for prediction of liability for drug-induced delayed ventricular repolarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: in vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT interval prolongation in diphenhydramine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

The application of in vitro methods to safety pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

"Conventional" antihistamines slow cardiac repolarization in isolated perfused (Langendorff) feline hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Age-related differences in the direct cardiac effects of cisapride: narrower safety range in the hearts of young rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Propranolol inhibits the human ether-a-go-go-related gene potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Electrocardiographic findings in patients with diphenhydramine overdose.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Identifiers

10.1016/J.VASCN.2007.03.003

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28217412&oldid=1369158611"